Curis (CRIS) Return on Equity [ROE] (2011 - 2026)
Curis (CRIS) posted Return on Equity [ROE] of -97.62% for Q2 2026, down 23.04 percentage points from the prior quarter.
Powered by 
Analysis
Curis (CRIS) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2024, Curis' Return on Equity [ROE] came in at -625.72%, down 488.62 percentage points from FY2023.
- Annual Return on Equity [ROE] has declined for three consecutive years, with a four-year change of -574.38 percentage points (FY2020 to FY2024).
- In prior years, Curis' Return on Equity [ROE] was -137.10% in FY2023 (-61.47 pp), -75.62% in FY2022 (-37.81 pp), -37.81% in FY2021 (+13.52 pp) and -51.33% in FY2020.
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q2 2024.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2021, with a gain of 5.43 percentage points; the weakest was Q2 2024, with a drop of 928.03 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Curis | 1.64 Mn | -32.55 Mn | - | -97.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -97.62% |
| Mar 31, 2026 | -74.58% |
| Jun 30, 2024 | -1,068.91% |
| Mar 31, 2024 | -318.36% |
| Dec 31, 2023 | -184.30% |
| Sep 30, 2023 | -156.01% |
| Jun 30, 2023 | -140.88% |
| Mar 31, 2023 | -115.04% |
| Dec 31, 2022 | -101.47% |
| Sep 30, 2022 | -92.94% |
| Jun 30, 2022 | -76.02% |
| Mar 31, 2022 | -57.78% |
| Dec 31, 2021 | -43.23% |
| Sep 30, 2021 | -33.07% |
| Jun 30, 2021 | -25.87% |
| Mar 31, 2021 | -19.92% |
| Dec 31, 2020 | -48.67% |
| Sep 30, 2018 | -878.38% |
| Jun 30, 2018 | -397.58% |
| Mar 31, 2018 | -251.27% |
API Access
Curis Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRIS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CRIS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRIS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();